When.com Web Search

  1. Ads

    related to: roche drug assistance program

Search results

  1. Results From The WOW.Com Content Network
  2. AIDS Drug Assistance Programs - Wikipedia

    en.wikipedia.org/wiki/AIDS_Drug_Assistance_Programs

    The programs are administered by each state with funds distributed by the United States government. In June 2007 the program provided coverage for 102,000 or 30% of those infected with HIV in the United States. Drug expenditures were $100.1 million in 2007 and $8.8 million in money spent on helping with insurance payments.

  3. ADAP Advocacy - Wikipedia

    en.wikipedia.org/wiki/ADAP_Advocacy

    ADAP Advocacy is an American national 501(c)(3) non-profit organization based in Washington, D.C., that is dedicated to promoting and enhancing the AIDS Drug Assistance Programs (ADAPs) and improving access to care and treatment for Persons Living with HIV/AIDS (PLWHA) in the United States and the U.S. Territories.

  4. Roche Fast-Tracks Obesity Drug Development, Eyes Over $3B ...

    www.aol.com/finance/roche-fast-tracks-obesity...

    The selected fast-tracked programs include: ... Roche plans to cut drug development costs by 20% and reduce the time it takes for drugs to move from discovery to the end of Phase 3 trials by 40% ...

  5. Allion Healthcare - Wikipedia

    en.wikipedia.org/wiki/Allion_Healthcare

    Allion Healthcare Inc. was the parent company of MOMSpharmacy based in Melville, New York primarily known for providing mail order HIV medications to patients who are primarily on Medicaid or the AIDS Drug Assistance Program (ADAP).

  6. Roche joins race for obesity drugs with $2.7 billion Carmot deal

    www.aol.com/news/roche-enters-obesity-drug...

    Roche agreed to take over obesity drug developer Carmot Therapeutics for $2.7 billion, joining a list global contestants seeking to challenge the dominant makers of weight-loss drugs Novo Nordisk ...

  7. UPDATE 2-U.S. approves Roche drug for emergency use ... - AOL

    www.aol.com/news/1-roches-actemra-gets-u...

    The U.S. Food and Drug Administration (FDA) said on Thursday it had issued an emergency use authorization (EUA) for Actemra to treat adults and pediatric patients hospitalized with COVID-19.